INVECTYS, MD ANDERSON AND CTMC ANNOUNCE STRATEGIC COLLABORATION FOR CAR T CELL THERAPY DEVELOPMENT
HOUSTON, June 16, 2022 (GLOBE NEWSWIRE) -- Invectys, Inc. (Invectys), The University of Texas MD Anderson Cancer Center and the...
Month: June 2022
Lenire Biosciences Completes License Agreement with University College London for VSN16R, A Novel Clinical Candidate Treatment for Fragile X Syndrome
SAN DIEGO, June 16, 2022 (GLOBE NEWSWIRE) -- Lenire Biosciences Inc., a biopharmaceutical company developing novel treatments for Fragile X...
GBS Inc. Enters into Exclusivity Agreement for an Acquisition of Unique Point of Care Diagnostic Screening Technology Focused on Opioids and Drugs of Abuse
- Intelligent Fingerprinting Limited’s commercial-stage, revenue-generating platform technology would provide an expanded product upon which to leverage the existing GBS...
Umoja Biopharma Presents Data on its Engineered Induced Pluripotent Stem Cell Platform at the 2022 International Society for Stem Cell Research Annual Meeting
SEATTLE, June 16, 2022 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune...
ABVC BioPharma Submitted Vitargus® Phase II Study Plan to Australia HREC
FREMONT, CA, June 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical...
WIMI Hologram Academy: The Application of Virtual reality online games in Information Communication in the 5G era
HONG KONG, June 16, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,...
22nd Century Group (Nasdaq: XXII) Appoints R. Hugh Kinsman as CFO
CFO of GVB Biopharma to Expand Role, Become CFO of 22nd Century GroupIntegration of GVB Biopharma Proceeding at a Rapid...
PepGen Reports First Quarter 2022 Financial Results and Recent Corporate Developments
BOSTON, June 16, 2022 (GLOBE NEWSWIRE) -- PepGen Inc. (“PepGen”), a clinical-stage biotechnology company advancing the next generation of oligonucleotide...
Broken Coast Cannabis Launches Full Spectrum ‘woah’
A New Summer Lineup of Premium Craft-Cannabis Products Including, Liquid Wax, BHO Vapes, and Premium Small-Batch Flower Now Available Across...
Cornerstone Pharmaceuticals Announces Published Data on CPI-613® (Devimistat) as an Effective Approach to Targeting Carcinoma Catabolism
Cranbury, N.J., June 16, 2022 (GLOBE NEWSWIRE) -- Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”), a company focused on rare cancer...
INmune Bio, Inc. Presents Data on Combination Therapy with INB03™ on Overcoming Resistance to HER2 Targeted Therapies in Breast Cancer
In pre-clinical models of trastuzumab resistant MUC4 HER2+ breast cancer, treatment with INB03™ decreases MUC4 expression, reverses resistance to trastuzumab...
Nova Mentis Files Patent on Diagnosing, Monitoring and Treating Neurological Diseases with Psychoactive Tryptamine Derivatives
mRNA Diagnostic Index to Measure Drug Treatment ResponseVancouver, British Columbia--(Newsfile Corp. - June 16, 2022) - Nova Mentis Life Science...
CBD of Denver Accelerates Expansion Plans with Strategic Priorities Set for Second Half of 2022
Denver, Colorado--(Newsfile Corp. - June 16, 2022) - CBD of Denver, Inc. (OTC Pink: CBDD), a cannabis roll-up company and...
Emerald Health Therapeutics Provides Bi-Weekly MCTO Status Update
Vancouver, British Columbia--(Newsfile Corp. - June 16, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the...
Biote Appoints Ross W. McQuivey, M.D. as Chief Medical Officer
Innovative physician leader brings over 20 years of experience to Biote’s executive team IRVING, Texas--(BUSINESS WIRE)--biote Corp. (“Biote” or the...
Savara Awarded Innovation Passport in United Kingdom (UK) for Molgramostim Nebulizer Solution (Molgramostim), a Novel Investigational Inhaled Biologic
Innovation Passport Awarded to Molgramostim for the Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP), a Rare Lung Disease The Innovation...
Senseonics Announces CE Mark Approval of the Eversense E3 Continuous Glucose Monitoring System
The long-term implantable E3 CGM system now approved for commercialization in select European markets GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE...
Encision Reports Fourth Quarter Fiscal Year 2022 Results
BOULDER, CO / ACCESSWIRE / June 16, 2022 / Encision Inc. (OTCPK:ECIA), a medical device company owning patented Active Electrode...
Biophytis Presents Preclinical Efficacy Data for Sarconeos (BIO101) in Spinal Muscular Atrophy (SMA), a Rare Neuromuscular Disease
PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / June 16, 2022 / Biophytis SA (NasdaqCM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis" or...
Angle PLC Announces Predicting Immunotherapy Response in SCLC
PARSORTIX SYSTEM DEMONSTRATES POTENTIAL IN PREDICTING IMMUNOTHERAPY RESPONSE IN SMALL CELL LUNG CANCERCTCs isolated by the Parsortix system can be...